PPARG and obesity disorder: The hypermetabolic 2 SD and 3 SD effects of Fgfr4+/-, Fgfr4-/-, and Acer1-/- contribute to resistance to obesity, while the effects of Pparg heterozygosity are modest at just over 1 SD.